NCT07651085Active, not recruiting
Biomarkers in Alzheimer's and Parkinson's Diseases for IA
Effects of Endogenous and Exogenous Risk Factors in Patients With Alzheimer's and Parkinson's Diseases Using Clinical Indexes and Endophenotypes (Biomarkers) as Inputs to Artificial Intelligence
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
Investigate whether endogenous and exogenous risk factors, the presence of pathological amyloid aggregates and alpha-synuclein in the CSF, brain connectivity, and some clinical and biological indices such as vigilance, general motility, the sleep-wake cycle, genomic instability and possible DNA damage may correlate with (or predict) the clinical condition of mild cognitive impairment (MCI) and dementia in patients with Alzheimer's disease (AD) and Parkinson's disease (PD).
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 65 (estimated)
- First submitted
- 29 Jul 2024
- Start date
- Feb 2024
- Primary completion date
- May 2026
- Lead sponsor
- IRCCS San Raffaele Roma
- Diseases
- Alzheimer disease, Parkinson disease
- NCT number
- NCT07651085
What you commit to
- Study type: Observational
- Planned participants: 65
- From Feb 2024 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other concomitant diseases;
- Presence of arrhythmia, heart failure or previous heart attack, peripheral vascular disease or impaired circulation, valvular disease (diseases affecting the aortic valve), other diseases known conditions, end-stage renal disease (ESRD), diabetes, neurological disorders (e.g example, tremors), bleeding disorder or taking prescribed anticoagulants, tattoo(s) on the wrist where you will wear the Samsung Galaxy Watch, you will have an implanted pacemaker, a defibrillator implanted heart or other implanted electronic devices.
Other illness
- Severe dementia;
Other
- Inability to sign the informed consent;
- Inability to participate in study procedures;
Who the study is looking for
- The subject must be over 60 years of age;
- The Subject must have a full understanding of the Italian language;
- The subject is available to participate in the phase telemonitoring.
Age in the registry: 60 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS San Raffaele Roma Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.